semaglutide compounding news FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Novo Nordisk is no longer
Description
They started low and slowly increased the dose over time
The mechanism involves multiple factors: reduced caloric intake, blood sugar adjustments, and the neurological effects of GLP-1 receptor activation in the brain
Studies show that gradual dose tapering produces better long-term outcomes than abrupt cessation
I encourage open communication
